Loading...
OTCM
EMGE
Market cap4kUSD
Jul 06, Last price  
0.00USD
Jan 2017
-99.88%
IPO
-99.00%
Name

Emergent Health Corp

Chart & Performance

D1W1MN
OTCM:EMGE chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
74.65%
Rev. gr., 5y
10.56%
Revenues
2m
+184.54%
0989,835183,120167,191119,567574,6131,635,026
Net income
-2m
L-22.75%
0121,027-67,498-79,125-288,764-2,107,450-1,628,073
CFO
-1m
L-35.67%
076,971-54,239-57,251-161,628-1,896,079-1,219,802

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.
IPO date
Dec 28, 2007
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT